These data present extracted design information from randomized controlled trials (RCTs) reported in abstracts presented at the Association for Resarch in Vision and Ophthalmology from 2007 through 20
This was a Phase IV multicenter, randomized, open-label study, with masking of the vision examiner, of the efficacy and safety of intravitreal ranibizumab 0.5 mg in subjects with macular edema followi
This dataset file contains the pertinent data including age, sex, spherical equivalent refraction, axial length, corneal endothelial cell density, intraocular pressure, uncorrected distant and near vi